Correlation Between THC Biomed and Molecular Partners

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both THC Biomed and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining THC Biomed and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between THC Biomed Intl and Molecular Partners AG, you can compare the effects of market volatilities on THC Biomed and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in THC Biomed with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of THC Biomed and Molecular Partners.

Diversification Opportunities for THC Biomed and Molecular Partners

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between THC and Molecular is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding THC Biomed Intl and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and THC Biomed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on THC Biomed Intl are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of THC Biomed i.e., THC Biomed and Molecular Partners go up and down completely randomly.

Pair Corralation between THC Biomed and Molecular Partners

If you would invest  0.10  in THC Biomed Intl on September 18, 2024 and sell it today you would earn a total of  0.00  from holding THC Biomed Intl or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

THC Biomed Intl  vs.  Molecular Partners AG

 Performance 
       Timeline  
THC Biomed Intl 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days THC Biomed Intl has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Molecular Partners 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Molecular Partners AG are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent essential indicators, Molecular Partners displayed solid returns over the last few months and may actually be approaching a breakup point.

THC Biomed and Molecular Partners Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with THC Biomed and Molecular Partners

The main advantage of trading using opposite THC Biomed and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if THC Biomed position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.
The idea behind THC Biomed Intl and Molecular Partners AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments